Get access

Essure: Hysteroscopic Sterilization

Authors

  • Marie Hastings-Tolsma CNM, PhD,

    Corresponding author
      Associate Professor, Nurse Midwifery, University of Colorado at Denver & Health Sciences Center, 4200 East Ninth Avenue #C-288, Denver, CO 80262. E-mail: marie.hastings-tolsma@uchsc.edu
    Search for more papers by this author
    • Marie Hastings-Tolsma, CNM, PhD, is Associate Professor at the University of Colorado at Denver & Health Sciences Center School of Nursing. She is also in full-scope faculty practice with the University Nurse-Midwifery Faculty Practice.

  • Priscilla Nodine CNM, MS,

    Search for more papers by this author
    • Priscilla Nodine, CNM, MS, is a PhD student in the School of Nursing and an instructor with the Department of Obstetrics and Gynecology at the University of Colorado at Denver & Health Sciences Center. She is also with the University Women's Care Faculty Practice.

  • Stephanie B. Teal MD, MPH

    Search for more papers by this author
    • Stephanie B. Teal, MD, MPH, is Assistant Professor of Obstetrics and Gynecology and the Director of Family Planning at the University of Colorado at Denver & Health Sciences Center. She is a gynecologist in the University Women's Care Faculty Practice.


Associate Professor, Nurse Midwifery, University of Colorado at Denver & Health Sciences Center, 4200 East Ninth Avenue #C-288, Denver, CO 80262. E-mail: marie.hastings-tolsma@uchsc.edu

ABSTRACT

Essure, a new female sterilization method approved by the US Food and Drug Administration, offers women a new option for controlling fertility. The technique is done without an incision, is hormone-free, and can be performed on an outpatient basis under local anesthesia. There are few or no side effects. It is important for providers to understand how the device works, appropriate candidates for use, and requirements for preplacement and postplacement management.

Get access to the full text of this article

Ancillary